Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Dandruff is linked to changes in the immune system of hair follicles and skin.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Mogamulizumab can cause hair loss and skin rashes.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Scientists turned rat thymus cells into stem cells that can help repair skin and hair.